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Lupus nephritis
. Part ll. A clinicopathological correlation and study of outcome
A.-M. HALLAND, W. D. BATES, R. D. TRIBE, R. COOPER, D. CHALTON, P. KLEMP
Summary
A 5-year retrospective study of lupus nephritis at Tygerberg
Hospital was performed in an attempt to document the clinical
and histological spectrum of the disease and to study the
outcome of the Illness. Activity and chronicity scores were
used in addition to the World Health Organisation classifica-
tion system. Of 55 biopsies from 51 patients reviewed, 6 were
class 11,13 class Ill, 32 class IV and 4 class V. There were 19
deaths and in 15 of these the histological classification was
IV. Renal failure and infections, often with uncommon patho-
gens, were the most important causes of death. Serum crea-
tinine values and creatinine clearance at the time of biopsy or
follow-up, and hypertension at follow-up showed a significant
relationship with outcome. WHO class IV was associated with
a poor outcome (P = 0,048) when compared with the other
WHO classes combined. Activity scores showed a significant
relationship to the outcome (P = 0,018). The anticardiolipin
antibodies IgG and IgM were not associated with WHO class
or outcome. The study revealed a spectrum of histological
results similar to that of other studies, with a high mortality
rate, particularly in class IV disease. Poor renal function,
persistent hypertension, histological classification IV, and
high activity scores were found to be important prognostic
indicators.
S Air Med J 1991; 79: 260-264.
Lupus nephritis is an important cause of morbidity and mor-
tality among patients with systemic lupus erythematosus
(SLE).l Therapeutic regimens remain controversial2 and con-
trolled trials are confounded by factors such as intercurrent
infection, malignant disease and death from non-renal causes.
Although SLE is relatively prevalent in the western Cape,
there has been little detailed documentation of lupus nephritis
in this region. A retrospective study of lupus nephritis at
Tygerberg Hospital was carried out to determine whether
there was an association between clinical, laboratory and histo-
logical parameters and to document the spectrum and outcome
of the disease in this region.
·Patients and methods
reviewed. Four patients underwent two biopsies, providing a
total of 55 specimens. All patients fulfilled the 1982 American
Rheumatism Association (ARA) criteria for SLE.3
Forty-seven patients were female (39 coloured, 5 white, 3
black) and 4 were male (2 coloured, 2 white). Mean age at
biopsy was 25,7 years (range 14,3 - 53,8 years). Mean duration
of follow-up was 1,26 ± 1,29 years. The number of ARA
criteria fulfilled by each patient is shown in Fig. 1 and the
frequency of the 7 most common ARA criteria in Fig. 2.
The following clinical data were documented at the time of
biopsy and at most recent determination: diastolic blood pres-
sure, serum creatinine level, creatinine clearance, 24 h pro-
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Fig. 1. The number of AAA criteria fulfilled by each study patient.-
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The records of 51 patients who underwent renal biopsies for
clinically significant lupus nephritis from 1983 to 1987 were
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Fig. 2. The frequency of the 7 most common ARA criteria fulfilled
by the patients.
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Fig. 3. Outcome of 51 patients in terms of WHO class of most
recent kidney biopsy.
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teinuria, and the treatment administered. Treatment protocols
were not standardised, and therefore no attempt was made to
correlate treatment with outcome. Outcome of the illness· as at
repeat biopsy or February 1988 was recorded as: death of the
patient; alive and maintaining renal function or on long-term
dialysis; and lost to follow-up. The following laboratory investi-
gations were performed at the time of biopsy and serially
during follow-up: the third and fourth components of comple-
ment and total haemolytic complement using a standard
nephelometric assay with Behring antisera; an indirect
immunofluorescence assay for antinuclear factor (ANF) and
anti-double-stranded DNA (anti-dsDNA), using rat liver sub-
strate and Crithidia lucilliae, respectively; and anticardiolipin
antibodies IgG (aCLG) and IgM (aCLM) using an enzyme-
linked irnmunosorbent assay (ELISA).4 The anticardiolipin
assay has been available at our institution since 1985.
Renal biopsies were classified according to the World Health
Organisation classification systemS and then semiquantitatively
scored. l These classification systems and the results of the
biopsies were fully discussed in part I of this article (see p. 256)
Statistical methods included Student's t-test, Fisher's exact
test, the X2 test and Wilcoxon's two-sample test. Significance
levels were adjusted using the Bonferroni procedure.
Results 25
Fig. 4. Treatment of 51 patients in terms of WHO class of most
recent kidney biopsy.
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Fig. 5. Boxplots showing the dlltrlbutlon of antlcardlollpln anti-
bodies IgM (aClM) and IgG (aClG) according to WHO cia... X
is the mean value (normal value of aClM = 0-37 units; normal
value of aClG = 0-34 units).
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The mean diastolic blood pressure at biopsy was 87 ± 17
mmHg and at follow-up 85 ± 17 mmHg. The diastolic blood
pressure at follow-up showed an association with the outcome
(P = 0,023). The mean serum creatinine value at biopsy and
follow-up was 133 ± 19 j.LmoVl and 245 ± 266 j.LmoVl,
respectively. There was an association between serum creatinine
level and outcome both at biopsy (P < O,(XH) and at follow-up
(P < 0,001). The mean creatinine clearance at biopsy and
follow-up was 67 ± 33 mVmin and 62 ± 52 mVmin, respec-
tively. There was an association between creatinine clearance
and outcome both at biopsy (P < 0,001) and at follow-up (P =
0,037). The mean 24-hour urinary protein excretion at biopsy
and follow-up was 2,2 ± 3,1 g and 2,13 ± 2,7 g, respectively.
Neither of these values was associated with the outcome.
The causes of death in 19 patients are noted in Table I. The
mean age at death was 27,6 years (range 14,7 - 55,8 years).
Fourteen of the patients were under 30 years of age. Autopsies
were performed on 9 patients. Two patients with end-stage
renal failure were successfully entered onto long-term dialysis
during the study period, 1 of whom died of staphylococcal
septicaemia (patient 8).
Figs 3 and 4 show the outcome of the illness and the
treatment administered according to WHO class, respectively.
WHO class IV was associated with a poor outcome (P =
0,048) compared with the other WHO classes combined;
however, WHO class IVb alone did liot show an association
with outcome compared with the other WHO classes combined.
There was no significant relationship between chronicity scores
and outcome, or chronicity scores and· creatinine clearance at
biopsy or follow-up. The association between activity scores
and outcome is shown in Table 11. There was a significant
relationship between activity scores and outcome (P = 0;018).
There was no significant relationship between complement
components or total haemolytic complement and WHO class.
There was no significant relationship between ANF and WHO
class, or anti-dsDNA and WHO class .. Boxplots of the distri-
bution of anticardiolipin antibodies according to WHO class
are shown in Fig. 5. Serial determinations over 36 months
were analysed to produce this composite picture. No determi-
nations were available on patients with class V histology, 2 of
whom transformed to class IVb before 1985. There was no
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TABLE I. MAJOR CAUSE OF DEATH, HISTOLOGY AND TREATMENT IN 19 PATIENTS
Patient Cause of death WHO class Immunosuppressive therapy
Infection
1 Miliary tuberculosis; defaulted IVa Prednisone
2 Cryptococcal meningitis III Prednisone, cyclophosphamide
3 Fulminant endocarditis IVb Prednisone, cyclophosphamide
4 Cytomegalovirus
pneumonitis, gastra-
intestinal haemorrhage IVb Prednisone, cyclophosphamide
5 Meningococcal septicaemia,
end-stage renal
failure - not accepted for
chronic haemodialysis IVb Nil
6 Streptococcal septicaemia IVb Prednisone, cyclophosphamide
7 Staphylococcal septicaemia,
acute renal failure - on
dialysis IVb Nil
8 Staphylococcal septicaemia,
end-stage renal failure - on
peritoneal dialysis III Prednisone, azathioprine
Haemorrhage/thrombosis
9 Disseminated intravascular
coagulation, pancreatitis,
intracerebral haemorrhage IVb Prednisone, cyclophosphamide
10 Mesenteric artery occlusion,
septic arthritis; anticardia-
Iipin antibodies present 11 Prednisone
Renal failure •
11 Acute renal failure - on
haemodialysis,
bronchopneumonia IVa Prednisone
12 Acute renal failure,
hypertensive encephalopathy;
defaulted IVb Prednisone, cyclophosphamide
13 Acute renal failure, sepsis IVb Prednisone, cyclophosphamide
14 End-stage renal failure - not
accepted for chronic
haemodlaly~ls, recurrent
endocarditis IVb Nil
15 End-stage renal failure - not
accepted for chronic
haemodialysis IVb Prednisone, cyclophosphamide
16 End-stage renal failure,
patient refused treatment IVb Nil
17 End-stage renal failure - not
accepted for chronic
haemodialysis IVb Prednisone
18 End-stage renal failure,
psychosis IVb Prednisone, cyclophosphamide
Unknown
19 Patient transferred elsewhere III Prednisone, azathioprine
TABLE 11. ASSOCIATION OF OUTCOME WITH ACTIVITY-
SCORES
x': P=0.018.
• Those lost to follow-up were excluded from the statistical analysis.
t ~~~~~'fA~:I. scores in 4 patients who underwent repeat biopsies were included
association between anticardiolipin antibodies and WHO class
or outcome.
The details of 4 patients who underwent second renal
biopsies are shown in Table Ill.
Discussion
Lupus nephritis in southern Mrica has been reported in a
number of f-ublications, as part of a larger .study of SLE in
most cases. -9 None of these reports has studied the role of
clinical, laboratory or histological features in predicting the
Outcome
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TABLE Ill. PROTEIN EXCRETION, WHO CLASS, ACTIVITY AND CHRONICITY SCORES IN
4 PATIENTS WHO UNDERWENT FOLLOW-UP BIOPSIES
Proteinuria ,
Biopsy g/24 h Treatment WHO class Activity Chronicity
1 1,0 Steroids, V 0 0
2 11,9 cyclophos- IVb 12 1
phamlde
1 Unknown Steroids V 0 0
2 1,4 IVb 14 1
1 1,1 Steroids III 5 2
2 7,5 IVa 8 1
1 0,03 Steroids 11 0 0
2 0,02 III 5 1
outcome of the disease. Activity and .chronicity scores have
been shown to predict the outcome of lupus nephritis more
accurately than WHO scores alone.2 Activity scores predict
decreased survival and are reported to be responsive to cortico-
steroid therapy.I,ID Chronicity scores reflect glomerular sclerosis
and correlate with diminishing renal function. In a IS-year
study of lupus nephritis, patients with chronicity scores of 2 or
3 were shown to develop progressive renal scarring with renal
failure if treated with steroids alone. 2 The activity and
chronicity scores thus assist in identification of patients who
will benefit from immunosuppressive therapy.
Our study found hypertension, which persisted at the most
recent follow-up, to be associated with a poor outcome, as was
poor renal function both at biopsy and follow-up. Leaker er
al. I found that survival in lupus nephritis is unaffected by age,
sex, nephrotic syndrome or hypertension. Elevated serum
creatinine levels at presentation were, however, associated with
a poorer prognosis in their study and that of Ginzler er al.!1
WHO class IV histology was associated with a poor outcome
in our study, despite previous reports that have queried the
prognostic value of the WHO system. 12 The activity index was
helpful in predicting the clinical outcome; however, the chroni-
city index proved disappointing in predicting renal impairment
or outcome.. The frequent early mortality from non-renal
causes and the short period of follow-up may have obscured
the true value of the chronicity index.
Serial renal biopsies provide valuable insight into the
frequent and complex histological transitions that take place in
lupus nephritis.u Despite therapy, the 4 patients who were
rebiopsied progressed to more proliferative forms of the disease,
reflected by increased activity and chronicity scores and clinical
deterioration. This supports the contention that a biopsy
should be regarded as but one point in a dynamic process!4
and that a repeat biopsy is indicated should the clinical picture
change significantly.
Anticardiolipin antibodies are associated with thrombotic
complications in SLE and with major organ involvement,
particularly of the central nervous system.15 It is unknown
whether anticardiolipin antibodies are associated with more
severe renal disease, particularly in view of the thrombotic
nature of activity features such as hyalin thrombi. We were
unable to demonstrate a correlation between levels of aCLG or
aCLM and WHO class using values at biopsy (data not
shown) Or serial determinations over a period of time. There
was no association between anticardiolipin antibodies and
outcome.
The prognosis for lupus nephritis has improved since the
advent of immunosuppressive drugs, and some centres claim
to be able completely to prevent progression to end-stage renal
failure with adequate therapy in these patients.! The outlook
for patients in less advanced countries, however, appears to be
less promising. Low socio-economic status and race other than
white are reported to be independent predictors of a poor
prognosis.!6 Harris er alY recently found SLE to be an
important cause of death in young hospitalised Jamaicans. The
mean age of onset of SLE was 25,7 years and mean age of
death 30,5 years. Overwhelming infection, often complicating
immunosuppressive therapy, was the most common cause of
death, followed by renal failure, haemorrhagic complications
and cerebral lupus.
Our study demonstrated a high mortality from both renal
and non-renal causes. A wide range of infections, including
the opportunistic organisms Cryprococcus and cytomegalovirus,
were encountered. A 15-year-old patient died within 24 hours
of final admission to hospital of fulminant infective endocarditis
involving all four heart valves. Four patients died from acute
deterioration in renal function, despite intensive immuno-
suppressive therapy, plasmapheresis, and in 2 instances acute
haemodialysis. The fulminant course of the disease and young
age of many of our patients is reminiscent of the Jamaican
experience17 rather than that reported from North America
and Australia.!·!6
We have documented the spectrum and outcome of lupus
nephritis in a group of patients followed up at a major
teaching hospital. Of the study group 63% had WHO class IV
histology, which was associated with a poor outcome. Stan-
dardised treatment protocols were not uniformly applied, thus
the role of immunosuppressive therapy could not be addressed.
However, progression to more active, severe disease despite
therapy was demonstrated in 4 repeat biopsies, suggesting that
lupus nephritis in the western Cape is an aggressive disease,
often unresponsive to therapy.
Late presentation, poor compliance, inadequate facilities for
long-term haemodialysis and death from non-renal causes are
important factors contributing to the high mortality rate in
this study. Controlled therapeutic trials of treatment for lupus
nephritis in this region are urgently needed.
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Demographic factors influencing consent
for cadaver organ donation
R. E. PIKE, D. KAHN, J. E. JACOBSON
Summary
The records of all donor referrals to Groote Schuur Hospital
over a 5!h-year period were retrospectively examined to
determine which factors influenced the families' decision on
organ donation. In 35% of these referrals the families were
not approached for consent. The reasons for this included
the potential donor being unsuitable for organ donation or
not meeting all the criteria for brain death. The effects of the
age, sex, race and the cause of death of the potential donor
on whether the family gave consent were investigated. This
study demonstrates that consent was given more readily
when the potential donor was aged ~ 10 years, that the sex
of the potential donor appeared to have no effect on the
decision by the family about organ donation, that black
families gave consent for organ donation less frequently than
families of other race groups and that consent was obtained
more easily when death was due to suicide.
S AIr ·Med J 1991: 79: 264-267.
The shonage of cadaver organ donors is a major problem in
solid organ transplantation. 1,2 The reasons for this include
failure to recognise potential donors combined with an apathy
among the medical profession about referring brain-dead
patients as potential donors. 3 If all potential donors were
referred by the medical profession, the number of refusals by
the public would be so few as to constitute no significant
problem. There also appears to be an· unwillingness among
cenain groups to donate organs (personal experience). To
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date, no comprehensive surveys have been conducted that
examine this issue. -
Two basic types of organ procurement legislation exist
world-wide today - presumed consent ('opt-out') and required
consent ('opt-in').4 The policy of presumed consent, which has
been adopted by most European countries,4 allows· for the
removal of organs from a cadaver without consent from the
family unless the deceased has indicated before his/her death
that he/she has an objection to organ donation. South Mrica,
like the rest of the English-speaking world,4 has a policy of
required consent where consent is either requested from the
next-of-kin or it is indicated by the donor before death (donor
cards/ MedicAlert discs).5 For a policy of required consent to
be effective, an informed, altruistic publici and a motivated
medical profession are required. Many potentially transplant-
able organs are lost because consent for organ donation cannot
be obtained from the next-of-kin.
In an artempt to determine whether there were any factors
that influenced families to give consent for organ donation, the
records of all donor referrals over a 5Yz-year period were
retrospectively examined. By highlighting these factors we
hoped to identify those groups of donor families, if any, which
needed to be approached for consent in any special way.
Subjects and methods
This retrospective study examined the records of all cadaver
donor referrals to the renal and cardiac transplant units at
Groote Schuur Hospital between 1 January 1984 and 30 June
1989.
Referral procedure
Potential organ donors were identified and cenified brain
dead (irreversible loss of all brain function) by the doctor in
charge of the patient. The standard criteria for the diagnosis of
brainstem death6 were used. Once cenified brain dead, the
